About Index Trending news
Analyze
Pricing
ViewRay

ViewRay

ViewRay

ViewRay is a medical device company focused on developing a simultaneous MRI-guided adaptive radiation therapy technology for the treatment of cancer

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$26,100,000
OrbiMed, Kearny Venture Partners, Acuta Capital Partners, +1
Post-IPO equity
$14,000,000
OrbiMed, Kearny Venture Partners, Xeraya Capital
Employees

Unknown size

Locations
HQ
Headquarters
$26,100,000 Post-IPO equity
prnewswire , Crain's Cleveland Business

ViewRay Raises $26.1 Million in Private Placement

$14,000,000 Post-IPO equity
MassDevice

ViewRay raises $14m in private placement

$30,000,000 Venture capital
FinSMEs

ViewRay Secures $30M | FinSMEs

$45,000,000 Venture capital (Series C)
FinSMEs

ViewRay Closes $45M Series C Venture Capital Financing | FinSMEs

$26,700,000 Venture capital
MassDevice

ViewRay closes $27m private placement – MassDevice

$50,000,000 Debt financing
prnewswire

ViewRay® Secures Up To $50M in Debt Financing From CRG

$15,000,000 Venture capital (Series D)
PE Hub

ViewRay Raises Fresh $15M for Its Medical Imaging Technology